TEXCELL, announces the opening of its subsidiary in Japan to offer a viral security services solution to biotechs and pharmaceutical industries in Japan.

Bernard PLICHON, Chairman and CEO (chief executive officer) of the TEXCELL group : “After expanding its viral safety activities in the United States, with TEXCELL-NA (TEXCELL North America), in a new unit in Frederick (Maryland) in 2012, and in 2016 in Europe with the acquisition of VivoScience in Germany, TEXCELL is now expanding its commercial activity in Asia for customers, biotechs and pharmaceutical industries”.

For more information, click here